Our Partners & Members
We are a program of the International Federation of Psoriasis (IFPA), inspired by developments in the non-communicable diseases (NCD) policy agenda that calls on civil society to advocate for a people-centered and integrated response to psoriasis.
Global Health Council
The Global Health Council is the leading membership organization supporting and connecting advocates, implementers and stakeholders around global health priorities worldwide. The Council is world’s largest membership alliance dedicated to advancing policies and programs that improve health around the world. Its diverse membership serves to raise awareness and catalyze action around important global health issues across a number of sectors. Representing over 150 countries across the globe, the Council’s mission is to use the power of collective voice to improve global health and wellbeing through informed investments and policies.
International Alliance oF DERMATOLOGY Patient Organizations
The International Alliance of Dermatology Patient Organizations (IADPO) – also known as GlobalSkin – is a global alliance serving patient organizations to improve the lives of dermatology patients worldwide. The not-for-profit organization, which is based in Canada, is focused on three pillars: Research, Advocacy, and Support. GlobalSkin is working with 100 patient association members ─ located in 37 countries representing more than 36 disease areas ─ to improve the lives of those affected by dermatological disorders throughout the world. We appeal as one voice to the World Health Organization and other key influencers to recognize the debilitating nature of dermatological disease so that more resources for research and treatment options are made readily available to those afflicted and in need of help.
International Alliance of Patients’ Organizations
IAPO is a unique global alliance representing patients of all nationalities across all disease areas and promoting patient-centred healthcare around the world. Our full members are patients’ organizations working at the international, regional, national and local levels to represent and support patients, their families and carers. Through IAPO’s 268 members, we represent 52 disease areas and over 71 countries worldwide. IAPO works in a creative and innovative way towards its vision of patient-centred healthcare and has a network that connects over 4,000 organizations and an estimated 365 million patients worldwide.
The NCD Alliance is a distinctive civil society network, uniting 2,000 organizations in over 170 countries. Since 2009, the Alliance has worked to combat global non-communicable diseases by collaborating strategically with the World Health Organization, United Nations and national governments.
IFPA became the first NGO to represent psoriasis in the NCD Alliance in 2016. Through this relationship, the Global Psoriasis Coalition strengthens its advocacy work and existing links with the WHO and shining a spotlight not just on psoriasis but also on various comorbid NCDs such as diabetes and cardiovascular disease.
Together with our partners, Almirall, Celgene, Leo Pharma, Lilly, Novartis, and SUN Pharma represent the Coalition’s core membership. Learn more about the ways in which our members interact with IFPA and the broader landscape of psoriasis and psoriatic arthritis advocacy work in our Terms of Reference.
International federation of psoriasis associations
The International Federation of Psoriasis Associations (IFPA) is a non-profit organization uniting national and regional psoriasis associations from around the world. As the key global psoriasis advocacy organization, IFPA campaigns on behalf of all people with psoriasis and psoriatic arthritis. Most psoriasis associations across the world are IFPA members. IFPA aims to empower members, improve living conditions for patients, raise awareness of psoriasis and psoriatic arthritis and cooperate with fellow stakeholders.
Register Your Interest and Learn More about membership
*We are a program of the International Federation of Psoriasis (IFPA), inspired by developments in the non-communicable diseases (NCD) policy agenda that calls on civil society to advocate for a people-centered and integrated response to psoriasis.